Table: begin end state 1 20 cytoplasmic 21 48 transmembrane 49 59 non-cytoplasmic 60 79 transmembrane 80 90 cytoplasmic 91 111 transmembrane 112 117 non-cytoplasmic 118 137 transmembrane 138 148 cytoplasmic 149 171 transmembrane 172 176 non-cytoplasmic 177 197 transmembrane 198 254 cytoplasmic 255 276 transmembrane 277 294 non-cytoplasmic 295 315 transmembrane 316 322 cytoplasmic 323 339 transmembrane 340 344 non-cytoplasmic 345 369 transmembrane 370 382 cytoplasmic 383 402 transmembrane 403 407 non-cytoplasmic 408 431 transmembrane 432 452 cytoplasmic
Input: >BPHYT_RS30250 FitnessBrowser__BFirm:BPHYT_RS30250 MNRSTAVNVQTFINEHPFSPFQWLVFFMCFIIVLLDGFDTAAIGFIAPSLIAEWGITRPA LAPVLSAALFGLACGALGSGPLSDRLGRRSLLLGSVLLFGVACLGSAFSTSIEQLTTLRF ITGVGLGAAMPNAVTMMGEYCPDRRRATVINLMFCGFPLGAAFGGFLAAWMIPHFGWRSV LLLGGITPLLLLIVLAIKMPESVRYMVANNKPVERIRAALARISSEAAQAGSFVMTETAP QTGGKGMAVVLSRSYIIGSVMLWIAYFMGLVIFYASINWMPILLKDAGLTPQRATLISAL FPLGGVGAVLCGVLMDRFNANRIIAACYALTAVSVYFIGQAVGNVGALVFIVFVAGVLMN TAQSSMPALAAAFYPTEGRGTGVAWMLGIGRFGGIAGSFLVAELTRRHFSFAGIFAMVAV AGLLACLALLIKQAARPHVANVGAPKAESFGH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server